|
1
|
Dunn MW and Kazer MW: Prostate cancer
overview. Semin Oncol Nurs. 27:241–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katahira K, Takahara T, Kwee TC, Oda S,
Suzuki Y, Morishita S, Kitani K, Hamada Y, Kitaoka M and Yamashita
Y: Ultra-high-b-value diffusion-weighted MR imaging for the
detection of prostate cancer: evaluation in 201 cases with
histopathological correlation. Eur Radiol. 21:188–196. 2011.
View Article : Google Scholar
|
|
3
|
Gosselaar C, Roobol MJ, Roemeling S, van
der Kwast TH and Schröder FH: Screening for prostate cancer at low
PSA range: the impact of digital rectal examination on tumor
incidence and tumor characteristics. Prostate. 67:154–161. 2007.
View Article : Google Scholar
|
|
4
|
Shi GH, Ye DW, Yao XD, Zhang SL, Dai B,
Zhang HL, Shen YJ, Zhu Y, Zhu YP, Xiao WJ and Ma CG: Involvement of
microRNA-21 in mediating chemo-resistance to docetaxel in
androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin.
31:867–873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YH, Li ML, Hsu MY, Pang YY, Chen IL,
Chen CK, Tang SW, Lin HY and Lin JY: Effects of a Chinese herbal
medicine, Guan-Jen-Huang (Aeginetia indica Linn.), on renal cancer
cell growth and metastasis. Evid Based Complement Alternat Med.
2012:9358602012. View Article : Google Scholar
|
|
6
|
Huang M, Hu YY, Dong XQ, Xu QP, Yu WH and
Zhang ZY: The protective role of oxymatrine on neuronal cell
apoptosis in the hemorrhagic rat brain. J Ethnopharmacol.
143:228–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chai NL, Fu Q, Shi H, Cai CH, Wan J, Xu SP
and Wu BY: Oxymatrine liposome attenuates hepatic fibrosis via
targeting hepatic stellate cells. World J Gastroenterol.
18:4199–4206. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hong-Li S, Lei L, Lei S, Dan Z, De-Li D,
Guo-Fen Q, Yan L, Wen-Feng C and Bao-Feng Y: Cardioprotective
effects and underlying mechanisms of oxymatrine against ischemic
myocardial injuries of rats. Phytother Res. 22:985–989. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q and
Su C: Antitumor activities of matrine and oxymatrine: literature
review. Tumour Biol. 35:5111–5119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song G, Luo Q, Qin J, Wang L, Shi Y and
Sun C: Effects of oxymatrine on proliferation and apoptosis in
human hepatoma cells. Colloids Surf B Biointerfaces. 48:1–5. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ling Q, Xu X, Wei X, Wang W, Zhou B, Wang
B and Zheng S: Oxymatrine induces human pancreatic cancer PANC-1
cells apoptosis via regulating expression of Bcl-2 and IAP
families, and releasing of cytochrome c. J Exp Clin Cancer Res.
30:662011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Zhang J, Luo J, Lai F, Wang Z,
Tong H, Lu D, Bu H, Zhang R and Lin S: Antiangiogenic effects of
oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated
VEGF signaling pathway. Oncol Rep. 30:589–595. 2013.PubMed/NCBI
|
|
13
|
Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao
Z, Sun H and Ding Y: Oxymatrine induces mitochondria dependent
apoptosis in human osteosarcoma MNNG/HOS cells through inhibition
of PI3K/Akt pathway. Tumour Biol. 35:1619–1625. 2014. View Article : Google Scholar
|
|
14
|
Song MQ, Zhu JS, Chen JL, Wang L, Da W,
Zhu L and Zhang WP: Synergistic effect of oxymatrine and
angiogenesis inhibitor NM-3 on modulating apoptosis in human
gastric cancer cells. World J Gastroenterol. 13:1788–1793. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu
W, Qi X, Zhu X, Pei Y and Lin H: Oxymatrine diminishes the side
population and inhibits the expression of β-catenin in MCF-7 breast
cancer cells. Med Oncol. 28(Suppl 1): S99–S107. 2011. View Article : Google Scholar
|
|
16
|
Vogler M, Weber K, Dinsdale D, Schmitz I,
Schulze-Osthoff K, Dyer MJ and Cohen GM: Different forms of cell
death induced by putative BCL2 inhibitors. Cell Death Differ.
16:1030–1039. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Silva MT: Secondary necrosis: the natural
outcome of the complete apoptotic program. FEBS Lett.
584:4491–4499. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frew AJ, Johnstone RW and Bolden JE:
Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.
Cancer Lett. 280:125–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hou J, Wang D, Zhang R and Wang H:
Experimental therapy of hepatoma with artemisinin and its
derivatives: in vitro and in vivo activity, chemosensitization, and
mechanisms of action. Clin Cancer Res. 14:5519–5530. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vazquez A, Bond EE, Levine AJ and Bond GL:
The genetics of the p53 pathway, apoptosis and cancer therapy. Nat
Rev Drug Discov. 7:979–987. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu W, Ge Y, Ojcius DM, Sun D, Dong H, Yang
XF and Yan J: p53 signalling controls cell cycle arrest and
caspase-independent apoptosis in macrophages infected with
pathogenic Leptospira species. Cell Microbiol. 15:1642–1659.
2013.PubMed/NCBI
|
|
22
|
Ben Sahra I, Laurent K, Giuliano S,
Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y,
Giorgetti-Peraldi S, Cormont M, Bertolotto C, et al: Targeting
cancer cell metabolism: the combination of metformin and
2-deoxyglucose induces p53-dependent apoptosis in prostate cancer
cells. Cancer Res. 70:2465–2475. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gomez-Lazaro M, Galindo MF, Concannon CG,
Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH and
Jordan J: 6-Hydroxydopamine activates the mitochondrial apoptosis
pathway through p38 MAPK-mediated, p53-independent activation of
Bax and PUMA. J Neurochem. 104:1599–1612. 2008. View Article : Google Scholar
|
|
24
|
Ramaiah MJ, Pushpavalli SN, Lavanya A,
Bhadra K, Haritha V, Patel N, Tamboli JR, Kamal A, Bhadra U and
Pal-Bhadra M: Novel anthranilamide-pyrazolo[1,5-a]pyrimidine
conjugates modulate the expression of p53-MYCN associated micro
RNAs in neuroblastoma cells and cause cell cycle arrest and
apoptosis. Bioorg Med Chem Lett. 23:5699–5706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deng Y and Wu X: Peg3/Pw1 promotes
p53-mediated apoptosis by inducing Bax translocation from cytosol
to mitochondria. Proc Natl Acad Sci USA. 97:12050–12055. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gogada R, Prabhu V, Amadori M, Scott R,
Hashmi S and Chandra D: Resveratrol induces p53-independent,
X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein
oligomerization on mitochondria to initiate cytochrome C release
and caspase activation. J Biol Chem. 286:28749–28760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bishayee K, Chakraborty D, Ghosh S,
Boujedaini N and Khuda-Bukhsh AR: Lycopodine triggers apoptosis by
modulating 5-lipoxygenase, and depolarizing mitochondrial membrane
potential in androgen sensitive and refractory prostate cancer
cells without modulating p53 activity: signaling cascade and
drug-DNA interaction. Eur J Pharmacol. 698:110–121. 2013.
View Article : Google Scholar
|
|
28
|
Liu Y, Yang Y, Ye YC, Shi QF, Chai K,
Tashiro S, Onodera S and Ikejima T: Activation of ERK-p53 and
ERK-mediated phosphorylation of Bcl-2 are involved in autophagic
cell death induced by the c-Met inhibitor SU11274 in human lung
cancer A549 cells. J Pharmacol Sci. 118:423–432. 2012. View Article : Google Scholar : PubMed/NCBI
|
